Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels

Alzheimer's Research and Therapy

Volumn 6, Issue 4, 2014, Pages

  Allen, Mariet ^a   Kachadoorian, Michaela ^a   Quicksall, Zachary ^a   Zou, Fanggeng ^a   Chai, High Seng ^b   Younkin, Curtis ^a   Crook, Julia E ^a   Pankratz, V Shane ^b   Carrasquillo, Minerva M ^a   Krishnan, Siddharth ^a   Nguyen, Thuy ^a   Ma, Li ^a   Malphrus, Kimberly ^a   Lincoln, Sarah ^a   Bisceglio, Gina ^a   Kolbert, Christopher P ^b   Jen, Jin ^b   Mukherjee, Shubhabrata ^c   Kauwe, John K ^d   Crane, Paul K ^c   Haines, Jonathan L ^e,f   Mayeux, Richard ^g   Pericak Vance, Margaret A ^h   Farrer, Lindsay A ⁱ   Schellenberg, Gerard D ^j   Parisi, Joseph E ^b   Petersen, Ronald C ^b   Graff Radford, Neill R ^a   Dickson, Dennis W ^a   Younkin, Steven G ^a   Ertekin Taner, Nilüfer ^a   more..

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BRIGHAM YOUNG UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MAPT PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN; CEREBELLUM; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; RNA ISOLATION; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL CORTEX; TRANSCRIPTION REGULATION;

EID: 84906518915     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt268     Document Type: Article

References (39)

1. Untangling the tau gene association with neurodegenerative disorders. Pittman AM, Fung HC, de Silva R, Hum Mol Genet 2006 15 188 R195
2. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, et al. Nature 1998 393 702 705
3. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B, Proc Natl Acad Sci U S A 1998 95 7737 7741
4. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M, Hum Mol Genet 1999 8 711 715
5. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M, Neurology 2001 56 1702 1706
6. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. Pittman AM, Myers AJ, Abou-Sleiman P, Fung HC, Kaleem M, Marlowe L, Duckworth J, Leung D, Williams D, Kilford L, Thomas N, Morris CM, Dickson D, Wood NW, Hardy J, Lees AJ, de Silva R, J Med Genet 2005 42 837 846
7. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Rademakers R, Melquist S, Cruts M, Theuns J, Del-Favero J, Poorkaj P, Baker M, Sleegers K, Crook R, De Pooter T, Bel Kacem S, Adamson J, Van den Bossche D, Van den Broeck M, Gass J, Corsmit E, De Rijk P, Thomas N, Engelborghs S, Heckman M, Litvan I, Crook J, De Deyn PP, Dickson D, Schellenberg GD, Van Broeckhoven C, Hutton ML, Hum Mol Genet 2005 14 3281 3292
8. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, PSP Genetics Study Group, et al. Nat Genet 2011 43 699 705
9. The role of variation at AbetaPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, et al. J Alzheimers Dis 2012 28 377 387
10. The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Myers AJ, Kaleem M, Marlowe L, Pittman AM, Lees AJ, Fung HC, Duckworth J, Leung D, Gibson A, Morris CM, de Silva R, Hardy J, Hum Mol Genet 2005 14 2399 2404
11. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van Deerlin V, de Silva R, Hardy J, Neurobiol Dis 2007 25 561 570
12. Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease. Laws SM, Friedrich P, Diehl-Schmid J, Muller J, Eisele T, Bauml J, Forstl H, Kurz A, Riemenschneider M, Mol Psychiatry 2007 12 510 517
13. An association study of common variation at the MAPT locus with late-onset Alzheimer's disease. Abraham R, Sims R, Carroll L, Hollingworth P, O'Donovan MC, Williams J, Owen MJ, Am J Med Genet B Neuropsychiatr Genet 2009 150B 1152 1155
14. The microtubule associated protein Tau gene and Alzheimer's disease-an association study and meta-analysis. Russ C, Powell JF, Zhao J, Baker M, Hutton M, Crawford F, Mullan M, Roks G, Cruts M, Lovestone S, Neurosci Lett 2001 314 92 96
15. Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease. Mukherjee O, Kauwe JS, Mayo K, Morris JC, Goate AM, BMC Genet 2007 8 3
16. Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition. Kauwe JS, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P, Galimberti D, Scarpini E, Morris JC, Fagan AM, Holtzman DM, Goate AM, Proc Natl Acad Sci U S A 2008 105 8050 8054
17. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Buee L, Delacourte A, Brain Pathol 1999 9 681 693
18. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration. Takanashi M, Mori H, Arima K, Mizuno Y, Hattori N, Brain Res Mol Brain Res 2002 104 210 219
19. Haplotype-specific expression of exon 10 at the human MAPT locus. Caffrey TM, Joachim C, Paracchini S, Esiri MM, Wade-Martins R, Hum Mol Genet 2006 15 3529 3537
20. Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus. Caffrey TM, Joachim C, Wade-Martins R, Neurobiol Aging 2008 29 1923 1929
21. MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Trabzuni D, Wray S, Vandrovcova J, Ramasamy A, Walker R, Smith C, Luk C, Gibbs JR, Dillman A, Hernandez DG, Arepalli S, Singleton AB, Cookson MR, Pittman AM, de Silva R, Weale ME, Hardy J, Ryten M, Hum Mol Genet 2012 21 4094 4103
22. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, Lincoln S, Bisceglio G, Georgescu C, Kouri N, Kolbert CP, Jen J, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Petersen RC, Graff-Radford NR, Dickson DW, Alzheimer's Disease Genetics Consortium, et al. PLoS Genet 2012 8 1002707
23. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Neurology 1984 34 939 944
24. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Younkin SG, Younkin CS, Younkin LH, Bisceglio GD, Ertekin-Taner N, Crook JE, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG, Nat Genet 2009 41 192 198
25. Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes. Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P, Alzheimer's Disease Genetics C, Cantwell LB, Dombroski BA, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Lunetta KL, Martin ER, Montine TJ, Goate AM, Blacker D, Tsuang DW, Beekly D, Cupples LA, Hakonarson H, et al. Arch Neurol 2010 67 1473 1484
26. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, et al. Nat Genet 2011 43 436 441
27. Robust relationship inference in genome-wide association studies. Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen WM, Bioinformatics 2010 26 2867 2873
28. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome. Barry WT, Kernagis DN, Dressman HK, Griffis RJ, Hunter JD, Olson JA, Marks JR, Ginsburg GS, Marcom PK, Nevins JR, Geradts J, Datto MB, J Clin Oncol 2010 28 2198 2206
29. lumi: a pipeline for processing Illumina microarray. Du P, Kibbe WA, Lin SM, Bioinformatics 2008 24 1547 1548
30. Model-based variance-stabilizing transformation for Illumina microarray data. Lin SM, Du P, Huber W, Kibbe WA, Nucleic Acids Res 2008 36 11
31. PLINK: a tool set for whole-genome association and population-based linkage analyses. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC, Am J Hum Genet 2007 81 559 575
32. Principal components analysis corrects for stratification in genome-wide association studies. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D, Nat Genet 2006 38 904 909
33. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA, Am J Hum Genet 2002 70 425 434
34. Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando SB, Aasly JO, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA, Petersen RC, et al. Mol Neurodegener 2012 7 13
35. Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease. Roder HM, Hutton ML, Expert Opin Ther Targets 2007 11 435 442
36. Genome-wide associations of gene expression variation in humans. Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R, Hunt S, Kahl B, Antonarakis SE, Tavare S, Deloukas P, Dermitzakis ET, PLoS Genet 2005 1 78
37. Cis-acting expression quantitative trait loci in mice. Doss S, Schadt EE, Drake TA, Lusis AJ, Genome Res 2005 15 681 691
38. The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment. Di Maria E, Cammarata S, Parodi MI, Borghi R, Benussi L, Galli M, Galimberti D, Ghidoni R, Gonella D, Novello C, Pollero V, Perroni L, Odetti P, Scarpini E, Binetti G, Tabaton M, J Alzheimers Dis 2010 19 909 914
39. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, Jun G, Destefano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thorton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Gerrish A, Schmidt H, Kunkle B, Dunstan ML, Ruiz A, Bihoreau MT, Choi SH, Reitz C, et al. Nat Genet 2013 45 1452 1458